News Releases
  Events & Presentations
  Corporate Governance
      Documents & Charters
      Board of Directors
      Committee Composition
  SEC Filings
  Stock Information
      Historic Stock Lookup
      Investment Calculator
  Annual Reports
  Email Alerts

Investors

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Optimer Pharmaceuticals, Inc.'s financial performance into perspective.

Recent Releases

Jul 29, 2010
Optimer Pharmaceuticals Submits Fidaxomicin Marketing Authorization Application for the Treatment of Clostridium difficile Infection

Jul 28, 2010
Optimer Pharmaceuticals to Present at August 2010 Investor Conferences

View all releases »

Events & Presentations

Aug 12, 2010 at 2:00 PM ET
30th Annual Canaccord Genuity Growth Conference

View all events & presentations »

Investor Relations Contact

Christina Donaghy
Corporate Communications Manager
Optimer Pharmaceuticals, Inc.
P:(858) 909-0736 ext.154
E: cdonaghy@optimerpharma.com

Print Print page
Email Email page

Stock Quote
NASDAQ:OPTR
$9.19   - 0.16
Jul 29, 2010
3:59 PM ET
Quotes delayed at least 20 minutes.
Data provided by eSignal.


Home | About Us | Product Pipeline | Research & Development | Resources | News & Press | Investors | Careers | Contact Us
© Copyright 2010 Optimer Pharmaceuticals, Inc. Powered by BlueSwitch.